Lv1
40 积分 2025-08-29 加入
Reply: Aspirin and GLP-1RAs—The missing confounders of empagliflozin for MASLD without diabetes mellitus?
1天前
求助中
Reply: Aspirin and GLP-1RAs—The missing confounders of empagliflozin for MASLD without diabetes mellitus?
1天前
已关闭
Effects of empagliflozin on liver fat in patients with metabolic dysfunction–associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial
2天前
已完结
Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
1个月前
已完结
Prognostic models for cardiovascular and kidney outcomes in people with type 2 diabetes: living systematic review and meta-analysis of observational studies
2个月前
已关闭
Large Language Models in Medicine: The Potentials and Pitfalls : A Narrative Review
3个月前
已完结
large language models in medicine
3个月前
已完结
皖公网安备34019202002308
